Allergan, Inc.
U.S. Administrative Headquarters
Morris Corporate Center III, 400 Interpace Parkway
Parsippany
New Jersey
07054
United States
Tel: 1 (862) 261-7000
Website: http://www.allergan.com/
About Allergan, Inc.
Allergan plc (AGN), headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing innovative branded pharmaceuticals, high-quality generic and over-the-counter medicines and biologic products for patients around the world.
Allergan markets a portfolio of best-in-class products that provide valuable treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular and anti-infective therapeutic categories, and operates the world's third-largest global generics business, providing patients around the globe with increased access to affordable, high-quality medicines. Allergan is an industry leader in research and development, with one of the broadest development pipelines in the pharmaceutical industry.
We’re Looking for the World’s Best
At Allergan, we are committed to recruiting and retaining the industry’s best and brightest employees and are proud to offer opportunities for military veterans at all levels across our company. We offer business, scientific, technical, engineering, sales & marketing and a variety of other positions here in the U.S. and around the world.
At Allergan, you will find an entrepreneurial style work environment where employees and employee teams are encouraged to apply their unique talents to grow, contribute, innovate and excel. We welcome your ideas. We provide the support, resources and encouragement that enable you to take your career to new heights. We focus on challenging you, challenging ourselves and driving success.
Commit to your future and join us. Learn more about our exciting career opportunities at www.allergan.com/careers.
YEAR FOUNDED:
1948
LEADERSHIP:
Founder: Gavin S. Herbert
CEO: Brenton L. Saunders
CFO: Maria Teresa Hilado
CLINICAL TRIAL:
Please click here for clinical trial information.
PRODUCTS:
All Products
1188 articles about Allergan, Inc.
-
Allergan Inc. Announces Quarterly Conference Call
4/9/2008
-
Allergan Inc. Comments on the United States Department of Justice Subpoena for the Production of Documents Relating to Promotional Practices of BOTOX(R) for Therapeutic Uses
3/4/2008
-
Allergan Inc. Shares Fall as U.S. Questions Botox Safety
2/8/2008
-
Medical Device Maker Allergan Inc. to Shut Irish Plant, Shift to Costa Rica, Loss of 360 Irish jobs
1/30/2008
-
Allergan Inc. Reports Fourth Quarter Operating Results
1/30/2008
-
Allergan Inc. Responds to Public Citizen's Allegation Regarding a Fatality Following BOTOX(R) Cosmetic Treatment
1/28/2008
-
Allergan Inc. Comments on BOTOX(R) (Botulinum Toxin Type A) Safety Profile
1/25/2008
-
Allergan Inc., the #1 Global Medical Aesthetics Company, and Clinique, the #1 Prestige Cosmetics Brand in the United States, Form Strategic Collaboration to Develop New Skin Care Line
1/24/2008
-
ACS Awarded $130 Million Contract to Provide IT Outsourcing Services to Allergan Inc.
1/16/2008
-
Allergan Inc. Announces Quarterly Conference Call
1/10/2008
-
Allergan Inc. Announces New Board Member; Dawn Hudson Appointed
12/7/2007
-
Allergan Inc. and Covidien Ltd Enter into Co-Promotion Agreement for LAP-BAND(R) Adjustable Gastric Banding System
11/12/2007
-
FDA Approves Allergan Inc. Combo Eye Drop for Glaucoma
10/31/2007
-
Novavax, Inc. and Allergan Inc. Terminate Manufacturing Supply Agreement
10/25/2007
-
Orthovita, Inc. and Allergan Inc. Sign Binding Term Sheet for Bovine Collagen Raw Material, Equipment and Technology License
10/19/2007
-
Allergan Inc. Enters Multi-Year Agreement with The Cosmetic Bootcamp
10/19/2007
-
Allergan Inc. Announces Quarterly Conference Call
10/12/2007
-
Ivivi Technologies, Inc. Receives Initial Order from Allergan Inc.; Marketing Efforts Underway
9/25/2007
-
Indevus Pharmaceuticals, Inc. Announces Allergan Inc. as New Partner for SANCTURA Brand
9/19/2007
-
Allergan Inc. (Jobs) Announces Agreement to Acquire Esprit Pharma, Inc. for $370 Million
9/19/2007